Adjuvanted subunit intranasal vaccine reduces SARS-CoV-2 onward transmission in hamsters
IntroductionMost COVID-19 vaccine trials have focused on recipient protection, not protection of their contacts, a critical need. As a subunit intranasal COVID-19 vaccine reduced nasopharyngeal virus more than did an intramuscular (IM) vaccine, we hypothesized that this vaccine might reduce onward t...
Saved in:
Main Authors: | Yongjun Sui, Swagata Kar, Bhavna Chawla, Tanya Hoang, YuanKai Yu, Shannon M. Wallace, Hanne Andersen, Jay A. Berzofsky |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2025.1514845/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Lipopeptide adjuvants for antibiotics and vaccines: the future step in the fight against multidrug-resistant and extensively drug-resistant pathogens
by: Chloé O. Sebilleau, et al.
Published: (2024-04-01) -
Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
by: Nimeet Desai, et al.
Published: (2025-02-01) -
Cross-protection against homo and heterologous influenza viruses via intranasal administration of an HA chimeric multiepitope nanoparticle vaccine
by: Yongqiang Zhao, et al.
Published: (2025-02-01) -
What is a vaccine?
by: Melissa K. Jones, et al.
Published: (2022-06-01) -
Influencing factors for influenza vaccination among the elderly
by: LI Yiyao, LI Xiaoju, SHEN Xiaoying, ZHANG Xianqi, ZHAO Li, ZHANG Yuhan, WANG Xinmeng
Published: (2025-01-01)